Skip to search formSkip to main contentSkip to account menu

GNE-900

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
492 GNE-900, an orally bioavailable selective CHK1 inhibitor, illustrates that optimal chemosensitization is schedule and tumor type dependent
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)